Posts published by our team from July 20-24, 2020:
Our author Ryan takes you through this study detailing the creation of yet another SARS-CoV-2 vaccine candidate. Researchers from Beijing created an inactivated vaccine, named BBIBP-CorV, against SARS-CoV-2 by altering an existing clinical isolate (HB02). Tests in monkeys showed its ability to protect against infection while displaying few side effects. A multiple dosage program appears to yield the best results.
Our author Lasya explains the central dogma and how DNA is like your grandma’s recipe book. Read to find out how we get from a recipe to the delicious muffin that is life!